Abstract: An analgesic/anti-inflammatory pharmaceutical dosage form which comprises an effective amount of an active ingredient selected from the group consisting of racemic 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, optically active forms thereof and pharmaceutically acceptable salts thereof, in combination with a pharmaceutically acceptable excipient or diluent, said dosage form being an intranasally administrable dosage form.
March 2, 2004
September 2, 2004
Recordati S.A., Chemical and Pharmaceutical Company, A corporation of Switzerland
Giancarlo Santus, Giuseppe Bottoni, Ettore Bilato